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Abstract
The purpose of this review-hypothesis is to discuss the literature which had proposed the concept that the mechanisms by
which infectious and inflammatory processes induce cell and tissue injury, in vivo, might paradoxically involve a deleterious
synergistic `cross-talk', among microbial- and host-derived pro-inflammatory agonists. This argument is based on studies of the
mechanisms of tissue damage caused by catalase-negative group A hemolytic streptococci and also on a large body of evidence
describing synergistic interactions among a multiplicity of agonists leading to cell and tissue damage in inflammatory and
infectious processes. A very rapid cell damage (necrosis), accompanied by the release of large amounts of arachidonic acid and
metabolites, could be induced when subtoxic amounts of oxidants (superoxide, oxidants generated by xanthine-xanthine
oxidase, HOCl, NO), synergized with subtoxic amounts of a large series of membrane-perforating agents (streptococcal and
other bacterial-derived hemolysins, phospholipases A2 and C, lysophosphatides, cationic proteins, fatty acids, xenobiotics, the
attack complex of complement and certain cytokines). Subtoxic amounts of proteinases (elastase, cathepsin G, plasmin,
trypsin) very dramatically further enhanced cell damage induced by combinations between oxidants and the membrane
perforators. Thus, irrespective of the source of agonists, whether derived from microorganisms or from the hosts, a triad
comprised of an oxidant, a membrane perforator, and a proteinase constitutes a potent cytolytic cocktail the activity of which
may be further enhanced by certain cytokines. The role played by non-biodegradable microbial cell wall components
(lipopolysaccharide, lipoteichoic acid, peptidoglycan) released following polycation- and antibiotic-induced bacteriolysis in the
activation of macrophages to release oxidants, cytolytic cytokines and NO is also discussed in relation to the pathophysiology
of granulomatous inflammation and sepsis. The recent failures to prevent septic shock by the administration of only single
antagonists is disconcerting. It suggests, however, that since tissue damage in post-infectious syndromes is caused by synergistic
interactions among a multiplicity of agents, only cocktails of appropriate antagonists, if administered at the early phase of
infection and to patients at high risk, might prevent the development of post-infectious syndromes. ß 1999 Federation of
European Microbiological Societies. Published by Elsevier Science B.V. All rights reserved.
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1. Prologue
Since the discovery of hemolytic streptococci by
Billroth and Ehrelich in 1877 (see [1]) this elusive
and enigmatic microorganism has occupied the at-
tention of numerous investigators who attempted
to unveil the mysteries behind its role in so many
apparently diverse clinical manifestations. These
span all the way from mild pharyngeal infections
to severe debilitating and often fatal manifestations
such as rheumatic fever, acute glomerulonephritis
and culminating in myositis, fasciitis, better known
today as the `£esh-eating syndromes', septic shock
and multiple organ failure [2^10]. Furthermore, the
fact that group A hemolytic streptococcal cell wall
and cytoplasmic structures also share common anti-
gens with human tissues (molecular mimicry) might
explain the pathogenesis of rheumatic fever and
acute glomerulonephritis [7] both categorized as
autoimmune and `horror autotoxicus' phenomena.
The autoimmune nature of rheumatic fever and
nephritis has led to attempts to develop an appropri-
ate vaccine which, together with penicillin treatment,
might prevent and also eradicate these post-infec-
tious complications (discussed in [2,4,5,7]). On the
other hand, no adequate therapies for the `£esh-eat-
ing syndromes' have been developed. What makes
streptococci so versatile is still enigmatic. However,
the possibility that tissue injury following severe
streptococcal infections might be induced not only
as a result of synergism among their own metabo-
lites, toxins and cell wall components, but mainly
when these agents engage in a deleterious `synergistic
cross-talk' with the host's own defense systems, is
paradoxical, but also highly realistic [2,11^14]. It is
also important to note that an e¡ective prevention of
post-infectious and in£ammatory sequelae, whether
caused by Gram-positive or by Gram-negative bac-
teria, might depend on the development of adequate,
quick, and inexpensive predictive markers, either in
the outpatient clinic or at the bedside, which might
herald their invasion of the bloodstream. Taken to-
gether, it is tempting to speculate that a deeper anal-
ysis of the pathophysiological events in streptococcal
infections and their sequelae might also serve to eval-
uate the role played by synergism among a multi-
plicity of pro-in£ammatory mediators in tissue dam-
age caused by other types of microorganisms which
may often result in sepsis, systemic in£ammatory re-
sponse syndrome (SIRS), multiple organ dysfunction
syndrome (MODS), multiple organ failure (MOF)
and the `£esh-eating syndromes'.
1.1. Streptococcal hemolysins interact with oxidants
and proteinases to kill targets
The notion that a `cross-talk' among streptococcal
toxins and proteinases and also among host-derived
oxidants and several of the membrane-damaging
agents and proteinases generated in infectious and
C
Fig. 1. Synergistic interactions in streptococcal sepsis. M-protein and -hyaluronate-positive group A hemolytic streptococci might adhere
to target cells via LTA. Metabolizing catalase-negative streptococci might then release large amounts of H2O2, the highly cytolytic and
cardiotoxic SLO, the non-immunogenic SLS, toxic shock syndrome toxin (TSST), streptokinase (SK) which can convert plasminogen to
plasmin, SH-proteinase, the spreading enzymes hyaluronidase (HYADASE), ribonuclease (RNASE), deoxyribonuclease (DNASE) which
might facilitate bacterial spreading causing cell injury, myositis, fasciitis and gangrene. Streptococcal SLO, SLS and binding of LTA-IgG
complexes can degranulate PMNs to release lysosomal hydrolases (ENZ), activate NADPH-oxidase resulting in the accumulation of
H2O2, which together with myeloperoxidase (MPO) catalyzes the formation of HOCl. H2O2 together with Fe2 can generate the highly
toxic OH radical. The PMNs also release the highly cationic and cytotoxic elastase and cathepsin G as well as bactericidal and cytotoxic
cationic proteins. Secreted PLA2 might release FFAs and highly cytolytic lyso-compounds (LYSO). All the extracellular agents might syn-
ergize among themselves to amplify cell damage. Chemotactic agents released at the site of streptococcal proliferation might recruit mac-
rophages (MO), might be activated by streptococcal LTA, TSST and PPG to generate reactive oxygen species, PLA2, proteinases, nitric
oxide (NO) which might induce severe hypotension. NO might also interact with PMN-derived superoxide to form the highly cytotoxic,
peroxynitrite (OONO3). The activated cells might also generate large amounts of TNF-K and cytotoxic and chemotactic cytokines which
trigger the activation coagulation (disseminated intravascular coagulopathy (DIC)) and the complement cascades. These multiple interac-
tions might lead to septic shock, SIRS, MODS, and MOF. Since tissue damage is most probably caused by multiple synergistic interac-
tion, and since clinical trials which had used single antagonists to prevent the onset of sepsis had invariably failed to prolong the lives of
septic patients, only `cocktails' of antagonists might prove bene¢cial to control sepsis and the £esh-eating syndromes. The dashed arrows
indicate which pathways of the in£ammatory processes might be inhibited by certi¢ed anti-in£ammatory agents. Agents coloured: red,
toxins; blue, oxidants; brown, streptococcal cell wall-associated agents ; green, enzymes; yellow, cytokines; violet, cationic protein.
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in£ammatory foci originated in 1959 [15]. Catalase-
negative group A hemolytic streptococci, which pro-
duced ample amounts of H2O2 and which also ex-
pressed on their surfaces the potent cell-bound mem-
brane perforator streptolysin S (SLS), collaborated
in a synergistic manner with a streptococcal serine
proteinase to injure and disintegrate Ehrlich ascites
tumor cells (a three-component synergistic system)
(Fig. 1). These ¢ndings have recently been fully cor-
roborated by showing synergy between streptolysin
O (SLO) and a streptococcal proteinase in cell injury
[16,17]. These observations established the basis for
the ``synergism concept of cellular injury in infec-
tious and in£ammatory processes'' [13,14]. It hy-
pothesizes that the catalase-negative hemolytic strep-
tococcus, and the gangrene-inducing clostridial
FEMSIM 1094 25-8-99 Cyaan Magenta Geel Zwart
I. Ginsburg et al. / FEMS Immunology and Medical Microbiology 25 (1999) 325^338 327
species, seem to share with activated phagocytes
strikingly similar pathogenetic properties. Both the
bacteria and phagocytes possess adhesion molecules;
they elaborate spreading enzymes (hyaluronidase,
proteinases, nucleases) and secrete membrane-perfo-
rating toxins and enzymes. They both destroy extra-
cellular matrix proteins and also spread to remote
tissue sites. But above all, they in£ict a deadly
blow on cells by synergizing among themselves. He-
molytic streptococci also share common antigens
with the human heart, kidney, connective tissue
and brain (molecular mimicry) which might explain
some of the autoimmune features of post-streptococ-
cal sequelae. These observations led us to speculate
that these microbial species and perhaps also certain
of the Gram-negative toxigenic bacteria might per-
haps be considered some kind of `forefathers' of
modern phagocytes (a converging evolutional phe-
nomenon which does not necessarily involve the gen-
eration of identical gene products) [12].
These speculations led to a series of investigations
which analyzed the role in cell damage of `cocktails'
composed of agents generated either by microorgan-
isms or by the host's own defense systems. These
included: streptococcal hemolysins and their cell
wall components, reactive oxygen and nitrogen spe-
cies, phospholipases, fatty acids, proteinases, cationic
polyelectrolytes, cytokines and additional pro-in-
£ammatory agents. All these agents might be simul-
taneously present in the milieu of infection and in-
£ammation. It is believed that this approach might
also shed new light on the complex events which lead
to sepsis, septic shock, SIRS, MOF and adult respi-
ratory distress syndrome (ARDS) (Fig. 1).
However, to protect against the synergistic e¡ects
of microbial and host-derived agonists there is ur-
gency to develop novel, safe, and practical therapeu-
tic approaches to deal with the deleterious e¡ects
caused by multifactorial systems, without at the
same time compromising patients' lives. It is also
important to stress that since in£ammation is a dou-
ble-edged sword [18,19], this issue constitutes a seri-
ous challenge to the future development of novel
therapeutic measures to control severe infections
and their sequelae.
The present review-hypothesis analyzes the publi-
cations which supported the supposition that tissue
damage in infectious and in£ammatory complica-
tions, whether caused by Gram-positive, Gram-neg-
ative [20] or other types of microbiota, involves a
paradoxical synergistic deleterious `cross-talk' among
microbial and host-derived defense systems (Fig. 1).
2. Synergistic interactions among a multiplicity of
pro-in£ammatory agonists
2.1. The role of oxidants
Since the discovery of the respiratory burst in
phagocytes [21^34], oxidants have been suspected
and also claimed to be dominant pro-in£ammatory
agonists, and research e¡orts to unravel the mecha-
nisms of cell damage in in£ammation have focused
mainly on the role of reactive oxygen species (ROS).
This stemmed from the following observations. (a)
In more than 100 human diseases, there was evidence
for an enhanced generation of ROS either before or
during the development of symptoms [25]. (b) Pa-
tients su¡ering from chronic granulomatous disease
syndrome whose neutrophils (PMNs) and macro-
phages possess a defective oxidase [31], kill either
catalase-positive bacteria or mammalian targets
only with great di¤culty. Nevertheless, catalase-neg-
ative bacteria (e.g. streptococci) are readily killed by
CGD phagocytes presumably because the bacteria
supply the missing H2O2 (a distinct collaboration).
These observations, however, also suggested that
some kind of bene¢cial/adverse cooperation between
phagocytes and bacteria might take place (see be-
low). (c) Supplementation of antioxidants markedly
enhanced resistance to tissue damage caused by ox-
idative stress [28]. (d) Exposure of cells in culture to
oxidants results in a steep decrease in ATP and anti-
oxidant thiols which was accompanied by DNA
damage characteristic of post-ionizing irradiation ef-
fects and by the inability to repair nuclear damage.
These injuries could however be prevented by the
supplementation of thiols and of additional antiox-
idants (reviewed in [33]).
It is also important to stress, however, that most
of the reports indicated that killing targets in vitro,
in media containing amino acids but devoid of serum
proteins, necessitated the employment of millimolar
(non-physiological) amounts either of H2O2 or of
HOCl [34]. This was ascribed to the presence, in all
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mammalian cells, of large amounts of a variety of
membrane-associated antioxidants, mainly catalase.
This was proven by the ability of the catalase inhib-
itors sodium azide and aminotriazole to destroy
heme proteins and thus allow micromolar amounts
of peroxide to injure the cells. A tight adhesion of
activated phagocytes, via adhesion molecules upon
their targets, was needed to deliver a `kiss of death'
via a synergism among their secreted agonists. This
created a niche which eliminated inhibitory agents
present in the medium, e.g. sulfur-containing amino
acids, taurine, and proteinase inhibitors, which could
inhibit both HOCl and elastase [34].
2.2. The role of combinations of oxidants, membrane
perforators and proteinases
While large amounts of oxidants killed cells in a
short period, many publications also stated that
most mammalian cells, tested in vitro, were relatively
resistant to high concentrations of a variety of pro-
teinases (trypsin, elastase, cathepsin G, plasmin).
These were capable of detaching cells from matrices
by destroying extracellular matrices, but rarely killed
them [13,14].
Perhaps, either for convenience or due to the wish
to avoid studying complex systems, most of the pub-
lished models on cell injury, today, usually tested the
potential pathogenetic role played by single agonists,
one at a time. However, several publications since
1988 which focused on synergistic mechanisms as a
plausible explanation for cell damage in infections
and in£ammation will be reviewed and brie£y dis-
cussed (Fig. 1).
Ehrlich ascites tumor cells injured by complement-
dependent cytotoxic antibodies (also a porin-forming
system) were rapidly disintegrated upon the addition
of streptokinase-generated plasmin [35]. Tumor cells
could also be killed more e¤ciently and in a syner-
gistic manner by combinations between the attack
complex of complement and hydrogen peroxide
[36]. A variety of mammalian cells treated with sub-
toxic, physiological (micromolar) amounts of a vari-
ety of oxidants (peroxide, ROO, OH, HOCl, NO,
oxidants generated by xanthine-xanthine oxidase,
paraquat, menadione) were nevertheless rapidly
killed (51chromium and 3H-arachidonate release as-
says), in a synergistic manner, by the presence of any
of a large series of subtoxic amounts of membrane-
damaging agents. These included: SLS [36^41] and
SLO [37], phospholipases A2 (PLA2) and C, lyso-
phosphatides, free fatty acids (reviewed in [13,14]),
the cationic proteins, histone, defensin [37,41,42,44],
and the attack complex of complement [32], tauro-
cholic acid, the xenobiotics ethanol, methanol and
lindane [42,43]. The latter also primed neutrophils
to generate enhanced amounts of ROS (reviewed in
[43]). Streptococcal hemolysins were shown to per-
meabilize neutrophil lysosomes resulting in the re-
lease of lysosomal enzymes and cationic proteins
from which might injure adjacent host cells (dis-
cussed in [13,14]).
Cell damage induced by combinations of oxidants
and membrane perforators was dramatically further
enhanced, also in a synergistic manner, by the inclu-
sion of a variety of subtoxic amounts of proteinases,
e.g. plasmin, trypsin, elastase, carboxypeptidase
[36,38^40]. Synergism among membrane perforators,
oxidants and proteinases also resulted in the release
of large amounts of arachidonic acid and metabolites
However, it is of special note that maximal release of
larger amounts of arachidonate always required the
presence of a proteinase [38^40]. Therefore, it will
not be surprising that other membrane-damaging
agents, mainly of microbial origin, might also syner-
gize with oxidants and proteinases to induce en-
hanced membrane injury [13,14]. Therefore it ap-
pears that the induction of even minor membrane
damage was su¤cient to overcome the potent anti-
oxidant capacities of cells.
In a more recent study [45] diethyldithiocarbamate
(DDC), a known anti-malarial agent, a SOD inhib-
itor and also a weak copper chelator, very signi¢-
cantly potentiated the killing of epithelial cells and
the release of arachidonate by synergizing with a
complex cocktail comprised of glucose oxidase
(GO)-generated H2O2, peroxyl radical (ROO), ni-
troprusside-generated NO, SLS, and histone. The
role of a combination of exogenous PLA2 and
H2O2 to kill epithelial cells has been studied
[46,47]. PLA2, which was not cytolytic to epithelial
cells, nevertheless became highly cytotoxic when
combined with subtoxic amounts of peroxide. Perox-
ide treatment resulted in the removal from the cells
of a large proportion of surface-associated glycosa-
minoglycans which exposed the `naked' membrane to
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an attack by non-cytotoxic amounts of PLA2. It is
also highly probable that arachidonate and addition-
al fatty acids released by PLA2 might also collabo-
rate with peroxide to further enhance membrane
damage as demonstrated with endothelial cells [36]
(see below).
Cell damage induced by combinations of PLA2
and peroxide was strongly inhibited by a novel
non-penetrating PLA2 inhibitor [47], a complex be-
tween carboxymethylcellulose and phosphatidyletha-
nolamine (CME). CME also protected epithelial cells
against killing by a highly cytotoxic cocktail com-
prised of SLS, SLO, peroxide, trypsin and DDC [48].
Neutrophil oxidants and elastase collaborated to
induce cell injury [45^55] and to enhance the degra-
dation of extracellular matrix proteolysis [56^58].
Neutrophil elastase and superoxide played an impor-
tant role in leukotriene D4 (LTD4)-induced neutro-
phil-mediated increase in pulmonary microvascular
permeability [59]. Cytolysis of target cells by PMA-
activated neutrophils could result from the coopera-
tive e¡ects of oxygen radicals and a membrane-
bound neutral serine proteinase [60]. Neutrophil-in-
duced IgG binding due to the combined action of
proteases and oxidants might explain the accelerated
destruction of red blood cells in in£ammatory dis-
eases [61]. Proteinases derived from Pseudomonas
strains extracted iron from transferrin which became
available for the formation, by neutrophils, of the
highly cytolytic hydroxyl radicals [62]. Pseudomonas
aeruginosa proteinases collaborated with human neu-
trophil elastase to injure human respiratory epithelial
cells [63]. Serine proteinases and defensins (neutro-
phil products) induced injury to lung epithelial cells
and modulated interleukin-8 production by macro-
phages [64]. Neutrophil-derived oxidants and elas-
tase were found to play a role in lipopolysaccharide
(LPS)-mediated renal injury [65]. An enhancement of
neutrophil-mediated injury to epithelial cells was in-
duced by a leukotoxin derived from Pasteurella hae-
molytica [66].
Phospholipase C from Clostridium perfringens and
Bacillus cereus elicited superoxide production by bo-
vine PMNs which could injure adjacent targets [67]
and PLC from C. perfringens also acted with oxi-
dants to injure endothelial cells in culture [40].
Lysophosphatides `primed ' human neutrophils for
enhanced generation of superoxide [68] and, when
combined with NO, enhanced cytolysis [69].
Cytosolic PLA2 potentiated H2O2 cytotoxicity of
kidney epithelial cells [70] and exogenous fatty acids
modulated the function and cytotoxic responses to
oxidant stress [71]. Arachidonic acid and additional
free fatty acids synergized with peroxide, ROO and
with trypsin to injure epithelial cells [36].
Tumor necrosis factor K (TNF-K) potentiated ox-
idant- and reperfusion-induced endothelial cell injury
[72] and also altered the cytotoxic e¡ects of peroxide
on hepatocytes [73]. Neutrophil oxygen radicals also
synergized with TNF and mono/polyunsaturated
fatty acids [74]. The possibility that cytokines might
also enhance the production and secretion of addi-
tional leukocyte-derived agonists (proteinases, cati-
onic proteins, phospholipases, etc.) should be ex-
plored (Fig. 1). The mechanisms by which oxidants
enhanced proteinase-mediated injury might be linked
to the ¢nding that oxidized proteins are more readily
digested by proteinases [75,76]. Oxidants such as
H2O2, which freely di¡use through the membrane,
might also activate apoptosis, endogenous metallo-
proteinases [34] and also deplete anti-oxidant thiols
to further amplify cell damage by apoptosis. How-
ever, a triad comprised of an oxidant, a membrane
perforator and a proteinase seems to constitute a
most powerful cell-damaging cocktail implicating
its possible role in tissue destruction in infectious
and in£ammatory sites (see below). These ¢ndings
also stress the paramount importance of `anti-cock-
tail' therapies for post-infectious sequelae (see below
and Fig. 1).
2.3. The role of microbial factors in apoptosis
Upon infection with pathogens, eukaryotic cells
might undergo programmed cell death (apoptosis)
as an ultimate response. Pathogens such as Shigella
£exneri have the ability to induce apoptosis of mac-
rophages which upon demise can elicit in£ammation
by releasing pro-in£ammatory cytokines which
might attract large numbers of neutrophils [77^79].
The molecular link between apoptosis and in£amma-
tion is the interleukin-1L-converting enzyme which is
activated during macrophage apoptosis and binds to
a secreted Shigella protein.
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2.4. The role of microbial cell wall components and
host-derived agonists
The main event which transpires following an in-
vasion of the bloodstream whether by bacteria from
the normal £ora (opportunistic invasion) or by viru-
lent microorganisms from exogenous sources is the
encounter of their exotoxins (hemolysins, phospholi-
pases) and of their cell wall components (LPS, lip-
oteichoic acid (LTA), peptidoglycan (PPG)) with hu-
moral factor and particularly with phagocytic cells.
These interactions are known to trigger the activa-
tion of deleterious cascades of reactive oxygen and
nitrogen species, coagulation, cytolytic and chemo-
tactic cytokines and the complement system. These
multiple agents are thought to synergize among
themselves to lead to severe sequelae such as sepsis,
septic shock, SIRS, MODS and MOF. Several ex-
perimental models were devised to address these is-
sues.
2.4.1. Experiments with LTA
This highly immunogenic but non-cytolytic agent
can be released from Gram-positive bacteria either
spontaneously or following treatment with neutro-
phil agents (see below). It binds to RBC membranes
via its lipid moiety [7,8] and to endothelial cells via
E-selectin. Human erythrocytes treated with protein-
ases (trypsin, papain), which presumably removed
surface cell-associated glucose aminoglycans to ex-
pose membrane phospholipids [42], could bind exces-
sive amounts of LTA [80]. Such cells were rapidly
agglutinated and were also lysed by complement.
Rabbits immunized with hemolytic streptococci,
which developed high titers of anti-LTA antibodies,
developed severe arthritis when LTA was injected
into their knee joints [81]. LTA might then interact
with antibodies to activate complement [82]. LTA-
anti-LTA complexes caused massive degranulation
of lysosomal enzymes from neutrophils and also in-
duced the release of superoxide and peroxide gener-
ation [83]. However, a further enhancement of ROS
generation also occurred if untreated PMNs were
added suggesting that migrating neutrophils might
amplify the respiratory burst by PMNs already
coated with LTA. An ampli¢cation of superoxide
generation by PMN-coated LTA was also observed
when small amounts of nuclear histone were added
together with anti-LTA IgG, suggesting that the cat-
ionic agent might have `opsonized' the immunoglo-
bulin and facilitated its interaction with the LTA-
coated PMN surface. Enhanced amounts of super-
oxide and peroxide were also generated by PMNs
which had been mixed either with LTA-coated ¢bro-
blasts or with LTA-coated epithelial cells suggesting
that LTA could be presented to PMNs by non-neu-
trophilic cells provided that anti-LTA globulin was
also present [83]. LTA-sensitized endothelial cells
were killed in a synergistic manner by combinations
of anti-LTA Ig and hydrogen peroxide.
LTA also stimulated the production of TNF-K
and also caused shock [84], induced the production
of TNF and NO [85,86] and also synergized with
peptidoglycan to induce shock and MOF [86]. Fi-
nally, the presence of anti-LTA antibodies in sera
of the population at large, and the fact that such
antibodies cross-react with LTA derived from all
Gram-positive bacteria, indicate that it might ac-
tively participate in tissue injury not only by `sensi-
tizing' cells to injury by antibodies and complement
but also because of its capacity to stimulate macro-
phages to generate cytokines.
2.4.2. The role of bacteriolysis and cell wall PPG
An adverse collaboration among neutrophil and
macrophage-derived agonists, microbial cell wall
components, and certain antibiotics leading to en-
hanced tissue injury might occur in severe infectious
conditions and in chronic granulomatous responses
[13,14]. It is paradoxical, perhaps, that the neutro-
phil- and eosinophil-derived cationic proteins defen-
sins, bacterial permeability increasing peptides [87],
elastase, cathepsin G, and lysozyme (reviewed in [88^
90]), which all function as distinct bactericidal
agents, might also contribute to cell and tissue in-
jury. Defensins acted in concert with peroxide to kill
cells [44]. All these cationic agents and L-lactam anti-
biotics (reviewed in [91^93]) were capable of trigger-
ing the activation of autolytic wall enzymes (mura-
midases), resulting in bacteriolysis [88] and the
massive release of LTA, LPS and PPG. Certain of
the neutrophil-derived cationic agents might also
mimic adhesion molecules capable of enhancing the
binding of neutrophils to targets [94]. Histones and
additional cationic polypeptides opsonized immune
complexes to enhance tissue injury [95] and cationi-
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zation of antigens might also increase their persist-
ence in tissues causing chronic in£ammation [89].
Polycations also acted as potent opsonins and as
stimulators of the respiratory burst in human neu-
trophils [88,89], mimicking immunoglobulins [90].
Although enhancement of ROS generation by phag-
ocytes might be bene¢cial for the host as it enhances
the killing of virulent microorganisms, excessive
amounts of ROS might also adversely injure host
cells [13,14].
The role played by non-biodegradable microbial
cell wall components (PPG-poly-PPG) as initiators
of chronic in£ammation and tissue destruction has
been extensively reviewed [96^99]. Cell wall com-
ponents of staphylococci, streptococci and mycobac-
teria are resistant to degradation by lysozyme and
by additional lysosomal enzymes either because of
the presence in the PPG of O-acetyl groups, (which
deter lysozyme activity) or due to the presence
in their cell walls of thick, impermeable layers of
lipids and waxes (discussed in [98]). These properties
contributed to the persistence, for long periods, of
non-biodegradable wall components within macro-
phages which became `chronically ' activated and
caused low-turnover granulomas and to tissue de-
struction. Streptococcal cell wall components have
also been shown to induce chronic arthritis in rats
[100,101] which could be prevented by prior treat-
ment with the muramidase mutanolysin, but not by
lysozyme.
While staphylococci were readily autolysed, in vi-
tro, by polycations (lysozyme, histones, elastase) pre-
sumably due to the activation of their autolytic wall
enzymes (muramidases) (reviewed in [88]), no degra-
dation of the cell wall occurred either within phag-
olysosomes of macrophages in culture [102] or in
macrophages in granulomas [96^101]. This raised
the suspicion that agents released into the phagoly-
sosomes following phagocytosis might have inter-
fered with the autolytic systems. Indeed staphylococ-
ci which had been treated in vitro either with H2O2
or with proteinases became highly refractory to au-
tolysis by polycations [103]. Sulfated polyanions
(heparin, dextran sulfate, suramine, Evans' blue, pol-
yanethole sulfonate) very markedly inhibited autoly-
sis of staphylococci induced either by cationic agents
[104,105] or by L-lactam antibiotics [106^108]. This
implies that in the milieu of in£ammation the accu-
mulation of sulfated polysaccharides due to the syn-
ergistic interaction between ROS and proteinases
(see above) might retard microbial degradation. It
is also of interest that sulfated polyanions inhibited
a large variety of lysosomal hydrolases from neutro-
phils (reviewed and discussed in [98]). However,
while on the one hand, the persistence of non-biode-
gradable cell wall components in tissues might ini-
tiate long-term destructive granulomas, on the other
hand, inhibition of bacteriolysis, in vivo, might, par-
adoxically, also be bene¢cial as it might diminish the
release of LTA, LPS and PPG from bacteria and
thus might delay the onset of sepsis (see below).
Non-biodegradable microbial cell wall components
might also serve as immuno-adjuvants to enhance
non-speci¢c immunity against microbial infections
and also against tumor cell proliferation [109,110].
One example is the capacity of a streptococcus-de-
rived cell wall preparation, OK-432, to augment cy-
totoxicity to tumor cells by inducing the formation
by blood monocytes of TNF-K, to induce synergism
with rINF-K but at the same time to boost non-spe-
ci¢c immunity to infections (discussed in [111]).
2.4.3. The role of LPS
Extensive studies on the chemical structure of LPS
and its biological properties [112,113] led to an un-
precedented explosion of basic science and clinical
investigations to unravel its involvement in the ini-
tiation of sepsis and MOF. Numerous studies have
also focused on the development of novel and so-
phisticated therapeutic strategies to cope with post-
infectious sequelae (see below).
The mechanisms of LPS release from Gram-nega-
tive bacteria are still not fully known but bacteriol-
ysis induced either by polycations [88] or by L-lac-
tams [91^93] seem to be involved in this process
during microbial invasion of the bloodstream. Un-
doubtedly, LPS is a scourge for clinicians because of
its multiple and deleterious pathophysiological ef-
fects ranging all the way from neutrophil stimulation
to release of excessive amounts of ROS [114], NO
and cytotoxic cytokines which in turn activate mac-
rophages to release enhanced amounts of ROS
[115,116], to the activation of the cascades of coag-
ulation and complement which might all act in syn-
ergy to induce sepsis, septic shock and eventually
MOF (discussed and reviewed in detail in [116].
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3. Why have e¡ective therapies for post-infectious
syndromes not been developed?
Paradoxically, perhaps, a coordinated deleterious
`cross-talk' among microbial exo- and endotoxins,
bacterial cell wall components and host-derived ago-
nists, might often occur in vivo. Therefore, the main
dilemma which confronts clinicians today is the in-
ability to e¡ectively combat these complicated syner-
gistic systems.
The reasons why treatment even with the most
advanced and sophisticated anti-in£ammatory strat-
egies was not e¡ective in sepsis, ARDS, ischemia-
reperfusion, trauma, myositis, and fasciitis were re-
cently extensively reviewed and discussed [116^131].
A recent review [132] also discussed the pros and
cons of 33 di¡erent strategies which had been o¡ered
in the last few years to treat post-infectious compli-
cations. These therapeutic measures included: anti-
biotics, monoclonal and polyclonal antibodies
against LPS, LPS binding proteins, polycations, in-
terleukin-1 receptor antagonist, anticoagulants and
inhibitors of complement, anti-adhesive molecules,
inhibitors of reactive oxygen and nitrogen species,
anti-proteinases, PLA2 inhibitors, pentoxyfylline,
tetracyclines, steroidal and non-steroidal anti-in-
£ammatory agents, inhibitors of bacterial trans-
location from gut, hemo¢ltration techniques, and
these in addition to conservative supportive meas-
ures.
Several explanations might be o¡ered as to why
therapeutic measures reported in numerous clinical
trials of sepsis invariably failed to show any signi¢-
cant e¡ects to control post-infectious sequelae caused
especially by Gram-negatives. (1) Immune strategies
might inhibit both deleterious (damaging host tis-
sues) and bene¢cial (augmenting host defense) e¡ects
of in£ammatory mediators. No easy solutions to
cope with this dilemma have been found [116,117,
128,130,131]. (2) The lack of reliable, quick, and
inexpensive early predictive markers to herald the
onset of sepsis delays e¡ective treatment to a point
of no return [131]. (3) Most of the large-scale clinical
trials in sepsis had attempted therapies by adminis-
tering only one antagonist at at time [128,130^133].
Disappointingly, however, multidrug therapies
achieved only a limited success [128]. Combination
therapies might worsen the patient's condition [134];
therefore, the slogan ``you are damned if you do, but
you are also damned if you don't'' might be very
appropriate to express the frustrations and the help-
lessness of clinicians who witness their patients going
into irreversible shock. It is of interest, however, that
Q-globulin therapy has shown promise in the treat-
ment of patients su¡ering from neonatal sepsis and
toxic shock syndrome caused by Gram-positive toxi-
genic bacteria [135^140]. The relative success in ther-
apy might presumably be ascribed to the fact that
antibodies present in Q-globulin preparations could
neutralize the main highly immunogenic, extracellu-
lar membrane-active factors (hemolysins, proteinases
and spreading enzymes LTA+antibodies+comple-
ment and the toxic shock syndrome toxin which
might act synergistically to injure issues [2,8,13,
14,48]. It might, however, also be speculated that
based on the `synergism concept of cellular injury',
a successful therapy of the serious `£esh-eating bac-
terial syndromes', and perhaps also of septic shock,
might bene¢t from the use of antibiotics combined
with `cocktails' comprised of Q-globulin, anti-protein-
ases, anti-oxidants and anti-cytokines, i.e. a multi-
drug strategy [4,8,128,130,132].
To illustrate the complex interactions which might
occur following the invasion of the bloodstream and
also the soft tissues by virulent group A hemolytic
streptococci Fig. 1 depicts which synergistic path-
ways of cellular injury might occur and which stages
might perhaps be inhibited by combinations of ap-
propriate anti-in£ammatory agents. These might
comprise Q-globulin as a potential source of antibod-
ies to most if not to all of the extracellular products
of hemolytic streptococci, including LTA and PPG,
anti-oxidants, proteinase inhibitors, PLA2 inhibitors,
monoclonal and polyclonal antibodies against pro-
in£ammatory cytokines, inhibitors of LPS, anti-co-
agulants, inhibitors of NO synthase, polyanions to
bind and neutralize the highly cytolytic cationic pro-
teins, etc. Novel drugs which might be e¡ective to
attenuate bacteriolysis and the massive release of
microbial cell wall components capable of activating
macrophages to release cytokines and NO might
help clinicians to control the deleterious conse-
quences of post-infectious sequelae (Ginsburg, sub-
mitted).
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4. Epilogue
Undoubtedly, the search for e¡ective and safe
`magic bullets' to control post-infectious complica-
tions is, today, one of the most urgent and burning
tasks of clinical medicine especially in the ailing anti-
biotic era. The hemolytic streptococcus might serve
as a useful model to evaluate the role played by
multiple synergistic interactions among pro-in£am-
matory agonists generated by the bacteria and by
the host, as main causes of the deleterious sequelae
seen after so many kinds of microbial infection.
Therefore, there is an urgency to develop drugs
and combinations of drugs which might be able to:
diminish the translocation of bacteria from the gut
into the bloodstream, attenuate and also control bac-
teriolysis induced either by cationic agents from
phagocytes or by certain antibiotics to neutralize mi-
crobial hemolysins, toxins and endotoxins, oxidants,
proteinases, phospholipases and the consequences of
coagulation and complement activation. The recent
reports that both the tyrosine kinase inhibitors tyr-
phostins [141,142] and dexabinol (HU-211), an ana-
damite derivative [143], were protective even if ad-
ministered to animals several hours after delivering a
lethal dose of LPS, are encouraging. Finally it is
hoped that the establishment of a brains trust and
`cross-talk' among researchers in the basic and clin-
ical sciences might provide the chance to devise safe
and e¤cient therapies for a large group of post-in-
fectious and often lethal manifestations against
which we still stand helpless.
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